Form D · Other Health Care
Phyto Management LLC
Washington, DC · CIK 0001669119
Offering snapshot reported Aug 9, 2017 · SEC filing
- Reported sold
- $450K Offering amount: $1.8M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $37.5K Reported outside-investor minimum
- First sale
- Aug 9, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 9, 2017 | Initial | $450,000 | No comparison | 2 | SEC filing |
| Mar 17, 2016 | Initial | $937,500 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292450
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Aug 9, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andras Kirschner | Director, Executive, Promoter |
| Edward Weidenfeld | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
888 17 Th Street Nw Suite 1250
Washington, DC, 20006
Washington, DC, 20006